Lab News
Find out what the RSP Lab has been up to!
Dr. Sklavenitis Pistofidis speaks to Blood Cancers Today about SWIFT-seq
Dr. Sklavenitis Pistofidis spoke to Blood Cancers Today about the need for new diagnostic assays that can be performed on blood samples and can provide multiple layers of accurate and prognostically relevant information, and highlighted the role SWIFT-seq could play in the experience of patients with Multiple Myeloma.
Dr. Sklavenitis Pistofidis presents at the Scientific Workshop of the Hellenic Society of Hematology
Dr. Sklavenitis Pistofidis was invited to present on the tumor-intrinsic and immune determinants of progression from the early stage of IgM MGUS to the late stage of overt Waldenstrom’s Macroglobulinemia at the Scientific Workshop of the Lymphoproliferative Disorder Group of the Hellenic Society of Hematology.
The RSP Lab launches!
The RSP Lab is an interdisciplinary group using multiomic tumor and immune profiling approaches to establish biologically informed clinical management for patients with Multiple Myeloma, Waldenstrom’s Macroglobulinemia, and other blood cancers.